Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check6 days agoChange DetectedRevision history now shows the addition of v3.4.3 and the removal of v3.4.2 in the study record history.SummaryDifference0.1%

- Check13 days agoChange DetectedVersion history shows updates to study status and location data across versions, including changes to recruitment status and site entries.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 has been added to the history, and the government funding notice and Revision: v3.4.1 have been removed.SummaryDifference0.8%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the page revision to v3.4.1. The previous revision v3.4.0 is no longer current.SummaryDifference0.8%

- Check48 days agoChange DetectedThe page now includes a glossary toggle and color-coded highlights for additions and deletions, with the revision label updated to v3.4.0. The text related to No FEAR Act Data has been updated.SummaryDifference1.0%

- Check62 days agoChange DetectedA new revision entry (v3.3.4) was added, and the previous revision (v3.3.3) was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.